JPRN-jRCT2080222374未知2 期
A M117101 phase II study in patients with primary palmar hyperhidrosis
适应症
试验速览
- 阶段
- 2 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 15age old 至 <= 64age old（—）
- 性别
- All
入选标准
- •1. Patients diagnosed with primary palmar hyperhidrosis
排除标准
- •1. Known allergy to any of the components in the investigational product
- •2. Participation in this study
研究者
相似试验
已完成
2 期
DP13 * A Phase II Study in Patients with Primary Aldosteronism to Evaluate the Efficacy, Safety and Tolerability of the Aldosterone Synthase Inhibitor, DP13, over an 8-week Treatment PeriodHormonal diseasesPrimary AldosteronismNL-OMON54894DAMIAN Pharma AG15
进行中（未招募）
1 期
Ipilimumab, nivolumab and tocilizumab in pretreated patients with advanced pancreatic cancer.Pretreated patients with advanced pancreatic cancer.MedDRA version: 21.1Level: LLTClassification code 10033605Term: Pancreatic cancer metastaticSystem Organ Class: 100000004864MedDRA version: 21.0Level: LLTClassification code 10033606Term: Pancreatic cancer non-resectableSystem Organ Class: 100000004864MedDRA version: 21.0Level: LLTClassification code 10033607Term: Pancreatic cancer recurrentSystem Organ Class: 100000004864EUCTR2019-004438-40-DKDepartment of Oncology, Herlev & Gentofte Hospital30
招募中
1 期
Phase I study of RO7187797 in patients with Multiple myeloma.Multiple myelomaJPRN-jRCT2061220045anki Toshihiro6
未知
2 期
An early phase 2 study of NST-141 in patients with atopic dermatitisPruritus associated with atopic dermatitisJPRN-jRCT2080221375TAIHO PHARMACEUTICAL CO.,LTD, NIPPON SHINYAKU CO.,LTD120
已完成
2 期
A phase 2 study of S-812217 in patients with major depressive disorderJPRN-jRCT2080225180SHIONOGI & CO., LTD.240